[1]
2018. Efficacy and Safety of Ixekizumab in a Randomized, Double-Blinded, Placebo-Controlled, Phase 3b Clinical Trial in Patients with Moderate-to-Severe Genital Psoriasis. SKIN The Journal of Cutaneous Medicine. 2, S1 (Feb. 2018), S8. DOI:https://doi.org/10.25251/skin.2.supp.8.